Nigerian Drugmakers Face Soaring Finance Costs Amid High Interest Rates

Nigerian pharmaceutical companies experienced a 47% surge in finance costs during Q1 2026, primarily due to high interest rates, which significantly impacted their profitability.

26 Jul, 00:08 — 26 Jul, 00:08

Post Share

Sources

Showing 1 of 1 sources

punch-ngMostly Factual1h ago

Drugmakers’ finance costs jump 47% amid high interest rates

Nigerian drugmakers’ finance costs surged by 47% in Q1 2026 due to high interest rates, impacting profitability. Learn how local pharma companies are navig Read More: https://punchng.com/drugmakers-finance-costs-jump-47-amid-high-interest-rates/

By Punch Newspapers

Read full article →

PERSPECTA

PERSPECTA

Nigerian Drugmakers Face Soaring Finance Costs Amid High Interest Rates

Sources

Drugmakers’ finance costs jump 47% amid high interest rates

Related Stories

US Pauses Iran Strikes Amid Houthi Attacks on Saudi Arabia

Tech Giants Back Open-Source AI Amid Industry Divide on Chinese Access

Samsung Challenges Meta with New Galaxy AI Glasses

Malaysian Contractor Loses Over RM50,000 in Government Official Scam

PERSPECTA